Adenoviral CD40 Ligand Immunotherapy in 32 Canine Malignant Melanomas–Long-Term Follow Up
Open Access
- 23 July 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Veterinary Science
Abstract
Malignant melanoma is a serious disease in both humans and dogs, and the high metastatic potential results in poor prognosis for many patients. Its similarities with human melanoma make spontaneous canine melanoma an excellent model for comparative studies of novel therapies and tumor biology. Gene therapy using adenoviruses encoding the immunostimulatory gene CD40L (AdCD40L) has shown promise in initial clinical trials enrolling human patients with various malignancies including melanoma. We report a study of local AdCD40L treatment in 32 cases of canine melanoma (23 oral, 5 cutaneous, 3 ungual and 1 conjunctival). Eight patients were World Health Organization (WHO) stage I, 9 were stage II, 12 stage III, and 3 stage IV. One to six intratumoral injections of AdCD40L were given every seven days, combined with cytoreductive surgery in 20 cases and only immunotherapy in 12 cases. Tumor tissue was infiltrated with T and B lymphocytes after treatment, suggesting immune stimulation. The best overall response based on result of immunotherapy included 7 complete responses, 5 partial responses, 5 stable and 2 progressive disease statuses according to the World Health Organization response criteria. Median survival was 285 days (range 20–3435 d). Our results suggest that local AdCD40L therapy is safe and could have beneficial effects in dogs, supporting further treatment development. Clinical translation to human patients is ongoing.Keywords
This publication has 65 references indexed in Scilit:
- Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus documentVeterinary and Comparative Oncology, 2013
- Chronic Inflammation in Cancer DevelopmentFrontiers in Immunology, 2012
- Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemiaCytotherapy, 2011
- The Role of Tumor-Infiltrating Immune Cells and Chronic Inflammation at the Tumor Site on Cancer Development, Progression, and Prognosis: Emphasis on Non-small Cell Lung CancerJournal of Thoracic Oncology, 2011
- Prognostic Evaluation of Ki67 Threshold Value in Canine Oral MelanomaVeterinary Pathology, 2010
- How does multiple testing correction work?Nature Biotechnology, 2009
- Efficient Adenovector CD40 Ligand Immunotherapy of Canine Malignant MelanomaJournal of Immunotherapy, 2008
- Morphology and Behavior of Primary Ocular Melanomas in 91 DogsVeterinary Pathology, 1986
- Canine Oral Melanoma: Comparison of Surgery Versus Surgery Plus Corynebacterium parvumCancer Investigation, 1986
- The role of spontaneous canine tumours in the evaluation of the aetiology and therapy of human cancerJournal of Small Animal Practice, 1975